Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Price indices track market movements to gauge overall levels. This intro explains what a price index is and why it matters for investors and analysts.
21,879 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A notable exit from a next-gen connectivity fund is shaking up how investors view sector funds. This analysis breaks ...
Digimarc's Q1 2026 results shed light on its trajectory for the year. This analysis breaks down revenue, cash flow, a...
The chatter around ad tech is hard to ignore, and Trade Desk sits at the center. This deep dive explains what fuels t...
Optex Systems faces a pivotal Q2 2026, balancing defense demand with supply chain shifts. This analysis breaks down t...
A Senate Banking Committee vote signaling bipartisan support for the CLARITY Act could unlock a clearer path for Bitc...
Figma stunned traders with a big Q1 2026 beat, lifting the stock on Friday morning. Here’s what happened, why it matt...
Investors are eyeing space stocks, but SpaceX remains private while Rocket Lab trades on the public market. This guid...
A Nvidia-backed AI infrastructure player is quietly reshaping how enterprises train and run AI. This piece breaks dow...
Taiwan Semiconductor sits near $394 as Q1 2026 beat and AI demand boost growth; investors ponder whether to buy, sell...
As AI accelerates, investors wonder if Nvidia can hit a six-trillion milestone. This guide weighs the math, current m...
NVIDIA guided higher-than-expected revenue for the coming quarter, but investors greeted the news with a muted respon...